Audit Trails in RDMS: Ensuring Data Integrity
In today's heavily regulated business environment, compliance with 21 CFR Part 11 is mandatory for companies within FDA-regulated industries utilizing electronic records and signatures, notably in the Life Sciences sector encompassing pharmaceuticals, biotechnology, CROs, and related fields. Non-compliance can lead to Regulatory repercussions, including warnings, fines, and other enforcement actions. This is where Audit Trails in the Regulatory Document Management System (RDMS) come into play.